Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FARXIGA
- SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
- The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
- proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2
- DAPAgliflozin for Renal Protection in Heart Transplant Recipients
- Long Term Clinical Efficacy of Sodium-glucose Cotransporter-2 (SGLT-2) Inhibitor in Cystinurics
- A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes
- Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer
- Bioequivalence of Dapagliflozin 10 mg Tablets Under Fed Conditions
- Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions
- The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study
- SGLT2-Inhibitors for Sleep Apnea in Heart Failure
- Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition
- SGLT2 Inhibition in Older Obese Adults With Pre-diabetes
- Dapagliflozin in Respiratory Failure in Patients With COVID-19
- Dapagliflozin Heart Failure Readmission
- Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
- Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial
- Dapagliflozin In Alzheimer's Disease
- Dapagliflozin Effects on Hypoglycemia
- Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus
- Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease
- Can Exenatide Prevent the Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
- A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
- Does Dapagliflozin Provide Additional Health Benefits To Dietary Counseling For Weight Loss?
- PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria
- Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
- Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
- Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- Effect of Anti-diabetic Drugs on Glycemic Variability
- Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery
- Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
- HbA1c Variability in Type II Diabetes
- Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
- Effects of Single Doses of Liraglutide and Dapagliflozin on Hyperglycemia and Ketogenesis in Type 1 Diabetes
- Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
- Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
- ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study
- Effect of Dapagliflozin on Inflammation and Endothelial Function
- SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
- Does Dapagliflozin Promote Favorable Health Benefits That Are Independent Of Weight Loss?
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
- An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin
- Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin
- Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
- Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?
- Dapagliflozin Effects on Epicardial Fat
Clinical trials list
click for details